Stockscreener 앱 받기
22.11
1.34%
-0.30
시간 외 거래:
22.11
Fresenius Medical Care Ag Adr 주식(FMS)의 최신 뉴스
Fresenius Medical Care publishes its Annual Report 2025: The power of care - Fresenius Medical Care
Advancing kidney care: Introducing high-volume hemodiafiltration to the U.S. - Fresenius Medical Care
Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar
Fresenius Medical Care marks World Kidney Day and National Kidney Month - Fresenius Medical Care
Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar Canada
Fresenius Medical Care's 2030 Ambition: Navigating a Pivotal Transition () - aktiencheck.de
5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand - Finviz
Research in brief: Nocturnal home hemodialysis - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $1.11, revenue topped estimates - Investing.com Australia
Fresenius Medical Care published Report on Form 20-F for fiscal year 2025 - Fresenius Medical Care
Fresenius Medical Care Q4 2025 slides: margin surge, flat 2026 outlook - Investing.com
Earnings call transcript: Fresenius Medical Care Q4 2025 beats EPS expectations - Investing.com
Fresenius Medical Care falls nearly 7% despite earnings beat - Investing.com South Africa
Fresenius Medical Care falls 7% after 2026 flat growth outlook and cost update - Investing.com
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band - Fresenius Medical Care
Uncovering Potential: Fresenius Medical Care's Earnings Preview - Sahm
Research in Brief: Hemodiafiltration and hospitalization burden in ESKD - Fresenius Medical Care
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Allstate Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Statement from Fresenius Medical Care on Upcoming Winter Storm - Fresenius Medical Care
Annual Press Conference 2026 - Fresenius Medical Care
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
6 New 5-Star Stocks - Morningstar
Research in brief: Implementation of Online High-Volume Hemodiafiltration - Fresenius Medical Care
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds By Investing.com - Investing.com South Africa
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds - Investing.com
Reasons to Add Fresenius Medical Stock to Your Portfolio Now - Finviz
Fresenius Medical Care accelerates second tranche of share buyback - Investing.com
Fresenius Medical Care accelerates second tranche of share buyback By Investing.com - Investing.com India
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned - Fresenius Medical Care
Finding purpose and perseverance: A dialysis nurse’s quiet heroism - Fresenius Medical Care
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now - Finviz
Fresenius Medical Care names Charles Hugh-Jones as new global CMO By Investing.com - Investing.com South Africa
Fresenius Medical Care names Charles Hugh-Jones as new global CMO - Investing.com India
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board - Fresenius Medical Care
DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Research in brief: Time on treatment - Fresenius Medical Care
Alphabet Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
1.21%
0.62%
자본화:
|
볼륨(24시간):